-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Haemonetics, Raises Price Target to $144

Benzinga·11/16/2026 14:00:07
Citizens analyst Daniel Stauder maintains Haemonetics (NYSE:HAE) with a Market Outperform and raises the price target from $115 to $144.